The prospective CATCH cohort study will evaluate the incidence of Takotsubo stunning and acute heart failure among 150 adults hospitalized for acute exacerbations of chronic obstructive pulmonary disease.
Cohort (n=150)
No
What is the incidence and clinical impact of Takotsubo stunning with acute heart failure during acute exacerbation of COPD?
The CATCH study is a prospective observational cohort designed to determine the incidence and clinical impact of Takotsubo stunning during acute exacerbations of COPD.
INTRODUCTION: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) may cause stress-induced transient acute cardiac dysfunction through myocardial stunning, in the form of exacerbation-triggered Takotsubo syndrome (referred to as Takotsubo stunning). Although prior studies suggest an association between AECOPD and transient cardiac dysfunction, existing evidence is limited to retrospective cohorts, case reports and expert consensus. Therefore, the incidence and clinical impact of Takotsubo stunning with acute heart failure (AHF) during AECOPD remain unknown and may be overlooked due to overlapping clinical symptoms. Cardiac Assessment and Takotsubo-stunning among COPD-exacerbations in-Hospital (CATCH study) aims to determine the incidence of Takotsubo stunning during AECOPD and to evaluate its clinical implication. METHODS AND ANALYSIS: CATCH is a prospective observational cohort study enrolling adults (≥18 years) admitted for AECOPD at Sahlgrenska University Hospital (Gothenburg, Sweden). Participants with chronic left ventricular systolic dysfunction (left ventricular ejection fraction 1). A sample size of 150 patients is required for detecting AHF differences (α=0.05, 80% power). ETHICS AND DISSEMINATION: The study received ethical approval from the Swedish Ethical Review Authority. All participants provided written informed consent. Results will be disseminated through peer-reviewed journals and scientific meetings. REGISTRATION DETAILS: The CATCH study is registered at ClinicalTrials.gov (NCT06597331). The reference number for ethical approval is 2024-02071-01 (with addenda 2024-05448-02 and 2025-05861-02).
Zeijlon et al. (2026) conducted a cohort in Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) (n=150). Echocardiographic screening for Takotsubo stunning vs. Screening-negative participants was evaluated on Incidence of reversible RWMA or left ventricular dysfunction and in-hospital clinical signs of AHF (Killip class >1). The prospective CATCH cohort study will evaluate the incidence of Takotsubo stunning and acute heart failure among 150 adults hospitalized for acute exacerbations of chronic obstructive pulmonary disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: